Guide for patients & caregivers
Factor V Leiden Positive Result: What Does Heterozygous or Homozygous Mean?
Factor V Leiden result explained: what heterozygous and homozygous mean, clot risk in context, pregnancy, oestrogen and travel questions, and DVT warning signs.
Prepared with AI assistance and checked against the cited sources. No independent clinician review has been completed. How we prepare articles
What does a positive factor V Leiden result mean?
A positive factor V Leiden result means you carry an inherited change in the F5 gene that makes blood slightly more likely to clot in the veins. It is a risk factor, not a clot and not a disease you can feel. MedlinePlus Genetics notes that only about 10 percent of people with the change ever develop an abnormal clot.
This guide is for adults reading a genetic or clotting test result that says factor V Leiden was detected, heterozygous or homozygous. It explains the wording and the questions worth raising. It cannot assess your personal risk or decide whether you need treatment.
Symptoms that need urgent care
The result itself causes no symptoms. What matters is recognising a possible clot. The NHS advises asking for urgent medical help if you think you have a deep vein thrombosis (DVT). Signs in the leg include throbbing pain, usually in the calf or thigh, swelling in one leg, red, blue or darkened skin around the painful area, and swollen veins. These can also happen in an arm.
Call emergency services if leg or arm symptoms come with breathlessness or chest pain, or if you have:
- Difficulty breathing that comes on suddenly.
- Chest or upper back pain, especially pain that is worse when breathing in.
- A very fast heartbeat or fainting. Coughing up blood also needs urgent same-day advice.
- Any of these symptoms during pregnancy or in the weeks after giving birth. The NHS also suggests contacting the maternity unit if you are pregnant and think you may have a DVT.
Heterozygous vs homozygous: what is the difference?
Genes come in pairs, one copy from each parent. Heterozygous means one copy of the factor V Leiden change and one usual copy. Cleveland Clinic notes that this is the most common result. Homozygous means two copies, one from each parent, and is uncommon.
MedlinePlus Genetics gives a sense of scale. It describes a background rate of about 1 in 1,000 people per year developing an abnormal clot. One copy of factor V Leiden raises that to about 3 to 8 in 1,000, and two copies may raise it as high as 80 in 1,000. These are population estimates, not a personal forecast. Your own history and other risk factors change the picture.
Some reports also mention a combination with another clotting gene change, such as the prothrombin gene mutation. MedlinePlus notes that risk is higher when factor V Leiden occurs together with a change in another clotting gene, so ask exactly what was tested.
How common is factor V Leiden and how is it found?
Factor V Leiden is the most common inherited form of thrombophilia, a tendency to clot more easily. MedlinePlus Genetics states that 3 to 8 percent of people with European ancestry carry one copy, and it is less common in other populations.
The protein made by the F5 gene, coagulation factor V, is normally switched off by a natural brake called activated protein C. With factor V Leiden, that brake works less well, so clotting stays active for longer. This is why some reports mention APC resistance. Cleveland Clinic explains that blood tests, including genetic testing, show whether the change is present. People often learn about it after a clot, because relatives have had clots, or through a wider genetic test.
Does it matter for pregnancy, the pill, HRT or travel?
These are the situations where the result is most often discussed. MedlinePlus lists increasing age, obesity, injury, surgery, smoking, pregnancy and oestrogen used for contraception or menopause symptoms as factors that add to clot risk in people with factor V Leiden.
Pregnancy: NHLBI notes that clot risk is higher during pregnancy and highest in the first 6 weeks after giving birth. MedlinePlus reports a modestly higher chance of recurrent miscarriage or later pregnancy loss, but also says most women with factor V Leiden have normal pregnancies. If you are pregnant or planning, ask your maternity team or haematologist how your result and personal history shape your care. A result alone does not predict how a pregnancy will go.
Contraception and HRT: NHLBI advises people at high clotting risk to talk with their provider about methods without oestrogen, such as some IUDs, progestin-only pills or implants, and barrier methods. Cleveland Clinic suggests discussing oestrogen-based contraception and HRT with your provider before using them. Do not stop current contraception without a plan, as that can lead to an unplanned pregnancy.
Travel: the NHS describes journeys of more than 4 hours by plane, car or train as a time of higher DVT risk. General NHS tips include wearing loose clothing, drinking water, avoiding alcohol and walking around when possible. Ask whether anything extra is advised for you.
Does factor V Leiden need treatment?
Cleveland Clinic states that there is no cure or treatment for the gene variant itself. Care focuses on treating any clot and lowering the chance of future clots, for example around surgery, hospital stays or pregnancy.
If you have had a DVT or pulmonary embolism, you may be taking a blood-thinning medicine (anticoagulant). NHLBI explains that treatment can last several months or a lifetime, depending on factors such as the cause of the clot. Do not stop or change a blood thinner because of this result or anything you read here. Talk to the prescriber first. The NHS medicine page for rivaroxaban, one blood thinner, warns that stopping suddenly can be dangerous.
Questions to ask your clinician
Take the full report to the appointment. These questions can help you understand what the result means for you.
- Am I heterozygous or homozygous, and was any other clotting gene or test checked?
- Why was I tested, and does the result change anything about my current care?
- How does my personal and family history of clots affect my risk?
- Which contraception or menopause treatment options suit me, and which should I avoid?
- If I become pregnant, who will plan my clot prevention, and when should I tell them?
- What should happen before surgery, a hospital stay or a long flight?
- If I take a blood thinner, how long is it planned for, and who reviews that decision?
- Should my blood relatives be offered testing, and would it change their care?
How can similar cases help you prepare?
On SameCase, patients and verified doctors share de-identified cases. Reading how other people with a factor V Leiden result discussed pregnancy plans, contraception or travel with their care team can help you spot questions you had not thought of. Every person's history differs, so similar cases cannot tell you your risk or replace advice from your own clinician. We suggest writing down the questions they prompt and taking them to your appointment.
Sources and further reading
- MedlinePlus Genetics: Factor V Leiden thrombophilia
- Cleveland Clinic: Factor V Leiden thrombophilia
- NHS: DVT (deep vein thrombosis) (reviewed April 2026)
- NHS: Pulmonary embolism (reviewed October 2026)
- NHLBI: Women and venous thromboembolism
- NHLBI: Venous thromboembolism treatment
- NHS: Rivaroxaban, a blood-thinning medicine
For patients & caregivers
Share your case and learn from others
Learn from doctors and other people's cases to find a way forward with your health problem. New cases are public immediately. Don't add names or identifying details.